Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DALIAH: Low-dose Interferon Alpha vs Hydroxyurea in MPN
NCT01387763Phase 3Completed
- Start
- Jan 2012
- Primary completion
- Jun 2020
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of peginterferon alfa-2b, interferon alfa in polycythemia vera (PV), essential thrombocythemia (ET), primary myelofibrosis (PMF). Started Jan 2012; status: completed.
02
Drugs
peginterferon alfa-2binterferon alfa
03
Conditions
polycythemia vera (PV)essential thrombocythemia (ET)primary myelofibrosis (PMF)
Beyond the preview
Go deeper on NCT01387763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01387763.